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A. Natale, L. Zimerman, K.H. Newby, E. Pisano’, R. Fanelli, F.Calleriza,
W. Reyes. Duke University/VA Medical Centec Durham, NC, USA, Casa de
Galicia, Montevideo, Uruguay
We asaessed whether AV node ablation and pacemaker implantation after
discontinuation of effective rate-control medical therapy for chronic atrial
fibrillation have a positive impact on quality of life and exercise performance.
Fowteen patienta entered the study. The mean age was 70 + 4 years. Each
patient underwent an echoeardiogrem before, the day after, and one month
following AV node ablation and pacemaker implant. Treadmill exercise and
quality of life measurements before and one month after ablation were also
obtained. At the time of the pre-ablation evaluation, 10 patients were treatad
with beta-blocker (BB) and digoxin, 2 patients with calcium antagonist and
BE, and 2 with calcium antagonist and digoxin. At the 1 month evaluation,
ejection fraction increased slightly (pre 39 * 6.0% vs 1 month 45 + 7.3%, p
< 0.01) but exercise duration and V02 mex did not change. However,quality
of life (pre 1.2 & 0.4 vs 1 month 2.9 + 0.2, p < 0.001) and physical limitation
(pre 12 + 3.0 va 1 month 20 + 3.5, p e 0.001) scores improved and severity
of symptoms decreased significantly (pre 37 * 6.6 vs 1 month 19 + 3.4, p
< 0.001) after the procedure. In conclusion: In patients with chronic atrial
fibrillation, discontinuation of “effective” therapy for rate-control followed by
AV node ablation and pacing seem to improve quality of life and symptoms




X. Huang, G.E. Sanduskyl, A. Elvan2, D.P.Zipes. Krarrneti Institute of
Cardiology Indiana Universifyand Purdue Univeralyatlndianapolis,
Indianapolis, IN, USA, 1Lilly Research Labs, Indianapolis, IN, USA,
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Netherlands
The changes in connexin43 (CX43)channel protein expression were studied
in 3 doga with atrfal fibrillation (AF) caused by chronic repid atrial pacing
for 3-S months. After RF catheter ablation of the AV junction, implanted
pacemakerewereusad to pace theatriaat20-30 Hzandtheventriclesat 1.33
Hz. All dogs had sustained AFdefined as spontaneous AF lasting =.24 hours
after turning off pacing. Three rightatria from AF dogeand four right atria from
control dcgs were fixed and standard paraffin slides were prepared for CX43
and wheat germ agglutinin (WGA) double labeling. CX43 localization was
visualized by confocal microscopy with fluorescence conjugated secondary
antibody against primary CX43antibody. WGA fluorescence conjugation was
used to visualize cell orientation. Quantitative data was acquired by using
a pixel analysis program (Bio-Rad). Our results demonstrated that, in the
control dogs, CX43 ia expressed in all layers of right atria except epicardial
layers Cx43typioslly residea at intercalated disk (ID) areaa and also at side-
side junctions. Chronic pacing causes over expression of CX43protein by a
90% (from 1.1% to 2.06% pixel area) increase of the staining density in the
right atria. The increase is found in all muscle layers of the right atria and
in both ID areas and side-side junctions. These results indicate that chronic
repid pacing can induce AF, which is accompanied by gap junctional protein
Cx43 over expression.
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S. Hoshida, N. Yamashita, J. Igarashi, K. Aoki, M. Nishida, M. Hori,
T, Kuzuya, M. Tada. Osaka University Medical School, Suita, Japan
Calcium (Ca)-dependent factors including cholesterol-induced changes in
membrane Ca permeability and Ca deposition into lesions are thought to
contribute to the formation and stability of the plaque during the early and late
stages of atherogenesis. Amlodipine has been shown to reduce atheroma
formation in cholesterol-fed rabbits and is thought to be csrdioproteerive.
We examined the effects of chronic amlodipine treatment (5 m~kglday) for
10 weeks on the size of infarct produced by 30-minute eoronaty oeeluaion
followed by 46-hour reperfusion in rabbits fed with/without 1% cholesterol for
10 weeks. Infarct size in cholesterol-fed rabbits (69.9 + 3.6%, n = 10) was
significantly larger than that in noncholesterol-fed rabbita (49.7 + 5.90A,n =
9, p < 0.05). The augmentation of the infarct size in cholesterol-fad rabbita
was reversed significantly by amlodipine treatment (46.4 + 6.3%, n =9, p <
0.05), although the treatment did not reduce infarct size in noncholesterol-
fed rabbits (51.0 + 4.7%, n = 6). Hemodynamic data including rate-pressure
produet did not differ significantly among these groupa during the course
of the experiment. Amlodipine treatment did not reduce plasma cholesterol
levels. However, a marked reduction in endothelium-dependent relaxation
induced by acetylcholine (10–6 M, 48 + 8VO) in the aorta of cholesterol-
fed rabbits was significantly reversed by amlodipine treatment (81 + 4%,
p < 0.05). These results suggested that chronic amlodipine treatment re-
duces infarct siza in cholesterol-fed rabbits possibly through the restoration
of atherosclerotic vascular disorder.
1958-391 Role of K~,p Channels on Action Potential
Characteristics in a Rabbit Model of Chronic
Myocardial Hypoxia
J.E.Baker, S.J. Contney, G.J. Gross, Z.J. Bosnjak. Medical College of
wkCOf7Si/7, Milwaukee, W/, IJSA
Increased tolerance to ischemia exhibited in chronically hypoxic immature
rabbit hearts is associated with increased activation of KATPchannels. We
determined whether exposure to hypoxia from birth alters the elaetrophysio-
Ibgieel characteristics of Purkinje fibers obtained from rabbits (n = 12/group)
which were raised in a normoxic (FI02 = 0.21) or hypoxic (FI02 = 0.12) envi-
ronment from birth to 9 days of age and the involvement of the KATPchannel.
The endooardial surface was exposed and impaled with microelectrodes
to record action potential characteristics from Purkinje fibers under control
conditions and following exposure to glibenclamide (3 &M). Data shown are
mean + SEM.
Normoxia Hypoxia
Control Glibenclamide Control Glibenclamide
Maximumdiastolicmtential –77* 1 –78 + 1 -80 + la –79+ lb
(mV)
Actionpotentialamplitude 104+ 2 107+ zb 109+ la 104+ 2b
(mV)
APD~ (mS) 78* 4 78& 4 71l5a 79* 5b
APD~ (ins) 121*4 119+4 110+58 120+ 4b
ap c 0.05,normoxiavshypoxia,bp c 0.05,controlw glibenclamide
Action potential duration (APD)W and APDW were significantly shorter in
hypoxic hearts compared with normoxic controls. Glibenclamide increased
APDW and APDW in hypoxic hearts to values similar to those observed in
normoxic controls. Glibenclamide had no effect on APD in normoxic hearts.
Maximum diastolic potential was more negative in hypoxic hearts and this
effect was attenuated by glibenclamide. We conclude that chronic myoeardial
hypoxia results in a shorter APD as compared with normoxic controls by
enhanced activation of KATPchannels.
PI RoleofEndo~enousAngiotensinllinGlucoae
Metabolism and Recovery of Postischemic
Mechanical Function During Reperfusion in
Ieolated Working Rat Hearts
W.R. Ford, A.S. Clanachan, G.D. Lopaschuk, R. Schulz, B.1.Jugdutt.
UnivereiiYof Alberta, Edmonton, Alberta, Canada
Cardioprotection during reperfusion maybe produced by blocking effects of
angiotensin (Angll). To determine the role of endogenous Angll in reeovery
of postischemic myocerdial function, we studied the effects of Angll type 1
(ATI) receptor blockade with Ioaartan on glucose metabolism [proton (H+)
production] and recoveryof mechanical function in isolated working ret hearfs
paced at 300 bpm and perfused with Kreb’s buffer (37QC)containing 1.2 mM
pelmitateprebound to3% BSA, 11mM [3H14C]glucoseand IOO@J/mlinsulin.
Aerobic perfusion (50 rein) was followad by global no flow ischemia (30 rein)
and reperiusion (30 rein) in presence or absence of Iosatin (1 #M) or the
selective adenosine AI receptor agonist Cyclohexyl-adenosine (CHA, 0.5
~M). During reperfusion, recoveries of LV.work and cardiac efficiency were
enhanced by CHA (p < 0.05) and depressed by Iosarfan (p < 0.05). Proton
production was reduced by CHA (p < 0.05) but unchanged by Iosarten.
Exogenous Angll prevented the deleterious effect of ATI blockade, sug-
gesting that postischemic recoveryof function depends on endogenous Angll
production,
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D95841 Prolonged Exposure of Csnine Coronsry Arteries
tos Nitric Oxide Donor Desensitizes Soiuble
Gusnylete Cyclese
D.G. Cable, P.Sorajja,H.V. Schaff. Mayo Clinic, l?dresteL MN, USA
Tolerance to nitric oxide donore is postulated to result from either substrate
limits on biodegradation ordesensitization ’of solubie guanylate cyclase. The
former is well characterized while the latter Is controversial. Paired canine
coronaries were exposed to either sodium nitroprusside (SNP) or pspaverine
in vaiying doses (10-9, 10-7, 10-5 M)for3 hrwithcontinuous recordingof iso-
matric tenaion. Solutions were exchanged every 30 min. The optimal length-
tension curve was not significantly different betwwn groups and calorimetric
cyanide was undetectable (< 0.2 @g/ml).Receptor-independent contraction
to KCI (6-60 mM) and reeeptor-dependent contraction to PGF~ (10-9–10-5
M) were aimilar between groups. Relaxations to calcium ionophore A23187
(10-9-10-6 M) wasattenuated in the 10”7 M and 10-5 M SNP groups but
not with 10-9 M SNP (n = 7 each, P <0.05, ANOVA). Relaxation to nitric
oxide (3 x 10-9-10-5 M) was markedly attenuated in the 10-7 M and 10-5
M SNP groupa but not with 10-9 M SNP (n = 7 each, P c 0.05). Relaxation
to nitric oxide was abolished with methylene blue pretreatment (10-5 M,
n = 4). Pretreatment with SNP did not alter vascular smooth muscie con-
tractions but markedly attenuated relaxation to both calcium ionophore and
authentic nitric oxide. These studies demonstrate desensitization of soluble
guanyiata cyclase in the intact coronav artety upon 3 hrexposure to SNP in
concentrations greater than 10-7 M.
D95842 Trestmentof lschemis-Repeffueion Demsge to theLstissimus Dorsi Muscle After Csrdiomyoplssty
Mobilization
V. Chekanov, V. Nikolaychik, G. Tchekanov, M. Rieder, D. Wankowski,
1.Hemandez, R. Eisenstein, P. Lelkes, D. Schmidt. Milwaukee Heart
Project, Milwaukee, WI, USA
Very often there are serious morphological changes in the Iatissimus dorai
muscle (LDM) used for csrdiomyopiasty (CMP) that mmpromise CMP re-
sults. These changes ars due to iechemia-repsrfusion damage affersubtotal
LDM mobilization. We hypothesized that application of an autologous bio-
logical glue (ABG) with pharmacological agenta (aprotinin, pyrrolostatin) to
the LDM would prevent ischemia-reperfusion damage, as well as increase
capillary ingrowth which would accelerate future angiogenesis.
Poeketawerecreated of ischemicand noniaohemicLDMtotestformuscle
damage and angiogenesie. One pocket was left free of ABG (control); one
received ABG only; one ABG with aprotinin; and one ABG with pyrrolostatin.
ABG was prepared from each animal’s citrated blood. Biopsies were taken
on days O,14,28 and 58.
Fibrosis, calcified neerosis, fiber degeneration, and leukocyte marination
were less in pockets with ABG than in the control pocket. The peak of these
changes waa noted on day 28 in the control pocket. No strong adhesions
between the ischemic LDM and adipose tissue wera noted in control pockets,
but were aeen in pockets with ABG.
In nonischemic LDM, capillaries oceupiad 4.0 + 0.24% of the area. The
results of the percent capillary area from the poeketa are below:
Control ABG ABG + Aprotinin ABG + Pyrrolostatin
Day 14 3.0* 0.9 4,1 * 0.4 5.2+ 2.1 7.9 * 1.9
Day 5S 3.s l 0.7 5,5l 0.2 S.5+ 1.1 9.4 * 1.9
E!31Suppression of Atherosclerotic Development in... . . . .Wstensbe Heritable Hyperlipidemic (WHHL)
Rabbits Treated with an Orai Anti-aliergic Drug,
Traniiast
T. Matsumura, K. Kugiyama, M. Ohgushi, S. Sugiyama, Y. Ohta, H. Doi,
H. Yasue. Kumamoto Universi~, Kumamoto, Japan
The atherosclerotic plaque beam many similarities to chronic inflammato~
conditions, and interactions between cellular components within the arterial
wall are considered to be easential in the progression of atherosclerotic
lesions. Tranilast, which is clinically used as an anti-allergic drug in Japan,
has been reported to be effective against the thickening of the intima after
endotheiial injuty by suppression of cell-mediated inflammato~ response. We
thus investigatedthe effects of tranilast on the development of atherosclerotic
changes in WHHL rabbits. WHHL rabbits (2 month old) were orally given
either 300 mglkg/day of the tranilast (Tranilast, n = 10) or vehicle (Vehicle,
n = 12) for 8 months. Tranilast-treatment suppressed percent aortic area
covered with plaque (Tranilast 39 + 5% va Vehicle 78 + 8%, p < 0.01) and
decreased contents of cholesterol and cholesterol esters in tha aortas. Little
difference was found in serum cholesterol levels between the 2 groups. The
cellular composition and phenotype of atherosclerotic plaques were analyzed
in immunohistochemical atudy.There was no difference in the percentage of
the RAM1l-posltlve microphage area in intimal plaques between Tranilast
and VehicJe.Most of the MHC claas II antigen (recognized as foreign by
T cells) -positive cells were macrophages, and the ratio of MHC class II
antigen-positive area to RAM1l-poaitive microphage area was markedly
lower in Tranilast as compared with that in Vehicle (Tranilast 18 + 7%
vs Vehicle 58 + 12%, p < 0.01). Furthermore, there was no difference
in the number of T cells between the two groups, but the percentages of
lnterleukin-2 (IL-2) receptor (CD25) positive cells (activated T cells) to pan
T cella was lower in Tranilast as compared with that in Vehicle, In an in
vitro study, the incubation of human peripheral bled mononuclear cells with
tranilast inhibitad the expression of MHC Class II antigen on monoeytea and
IL-2 receptors on T cells activated with IFN-y and IL-2, respectively. The
results indicated that tranilaat suppressed the atherosclerotic development
by downregulating the immune activation in atheromatous plaque.
m LOn~-term~iia~Prii TheraPYLimitsLefl
Ventricular Diastolic Dysfunction with Depressed
Systolic Function in Myocardiai Infarcted Rats
Y.Takemoto, M. Yoshiyama, K, Takeuchi, T. Shimada, K. Akioka,
M. Teragaki,J. Yoshikawa. First Depanment ofkrterna/ Medicine, Osaka
City University Medical School. Osaka, Japan
The purposes of this study were toasaessthe effeclof angiotensin mnverting
enzyme inhibitor (ACEI), cilazapril (1 m@kg/day) on left ventricular diaetolic
dyafunetionwith systoiicdysfunetion in myocardial infarcted (Ml) rats by using
echoeardiography and to analyze cardiac gene expression by northern blot
analysis. ACEI wea administered after Ml. On 1 and 3 months (M) after Ml,
left ventricular funciion were measured and mRNAs in cardiac tiseue were
analyzed. LV end-diastolic dimension (LVDd) and ejeclion fraction (EF) on 1
M were 9.7+ 0.5 mm and 34+ 4Y0,respectively,and LVDd on 3 M increased
to 10.4 + 0.3 and EF decreaaed to 30 + 6%. ACEI prevented an increase
of LVEDV (8.2 + 0.3 mm; p < 0.01) and improved FS (45 + 8%; p < 0.05)
on 1 M and also on 3 M. WA velocity ratio (E/A) and E wave deceleration
(E deee.) increased to 9.5+ 2.2 and 26.3+ 2.6 mkz on 1 M after Ml. ACEI
prevented the increase of E/A (4.2+ 0.5; P < 0/05) and E dece. (26.3+ 2.8
mkz; P c 0.05) on 1 M after Ml, and those on 3 M after Ml. The left and
right ventricular weight significantly increased after Ml, which were pravented
by ACEI. The gene expressions of j+myosin heavy chain (MHC), u-skeletal
aetin, atrial natriuretic peptide (ANP), collagen 1,Ill, in the nonischemic left
ventricular myoeardium increased by 1.8-, 2.9-, 4.2-, 3.0-, 2.6-fold on 1 M,
respecfivaly (p c 0.01) and RValso increased. ACEI significantly suppressed
theae increased gene expreaaions of nonischemic LV and RV. On contrary,
SR Ca-ATPase in nonischemic and RV decreased to 0.7- and 0.5- foid,
respectively,on 3 M after Ml and ACEI prevented them. In conclusion, ACEI
prevented the change of the properties of the myocardium and progressive
diaetolic and syetolic dysfunction by left ventricular remodeling after Ml.
Cone/usiorr.’ABGwith pharmacological agents can accelerate the healing
process and angiogenesis, and provide an organic bridge belween the LDM
and the myocardium after cardiomyoplasty.
